Literature DB >> 12792752

Extracellular matrix remodeling may predominate over hepatocyte injury in hepatocellular carcinoma development.

Hitoshi Yoshiji1, Shigeki Kuriyama, Junichi Yoshii, Yasuhide Ikenaka, Ryuichi Noguchi, Koji Yanase, Tadashi Namisaki, Masaharu Yamazaki, Hirohisa Tsujinoue, Hiroo Imazu, Hiroshi Fukui.   

Abstract

It has been suggested that both extracellular matrix (ECM) remodeling and persistent hepatocyte injury play important roles in liver carcinogenesis process. It is, however, still controversial which factor plays a predominant role. The aim of the present study was to examine the role of each factor in the liver enzyme-altered preneoplastic lesions, focusing on the relationship between the hepatocyte injury and fibrosis extension. The effects of two similar herbal medicines (Sho-saiko-to and Saiko-keishi-to: TJ-9 and TJ-10, respectively) were elucidated on the hepatocyte injury, fibrosis and preneoplastic lesions development using a choline-deficient-L-amino acid-defined (CDAA) diet rat liver carcinogenesis model. TJ-9 prevented fibrosis and glutathione S-transferase placental form (GST-P)-positive preneoplastic lesion development without reducing the hepatocyte injury as indicated by the serum markers. TJ-10 significantly protected against the hepatocyte injury. However, it did not exert any inhibitory effect on fibrosis and the development of preneoplastic lesions. Our in vitro study revealed that TJ-9 markedly suppressed the hepatic stellate cell activation whereas TJ-10 did not. These results suggested that the ECM remodeling plays a more important role than the persistent hepatocyte injury in the liver enzyme-altered preneoplastic lesion development in the rat.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792752

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  1 in total

1.  Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats.

Authors:  Xu-Jia Chen; Wen-Jing Liu; Meng-Liang Wen; Hong Liang; Shao-Mei Wu; Yun-Zhen Zhu; Jiang-Yuan Zhao; Xiang-Qian Dong; Ming-Gang Li; Li Bian; Cheng-Gang Zou; Lan-Qing Ma
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.